Millennium Management’s Foamix Pharmaceuticals FOMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-345,100
Closed -$1.05M – 4848
2019
Q3
$1.05M Sell
345,100
-486,925
-59% -$1.37M ﹤0.01% 2824
2019
Q2
$1.98M Buy
832,025
+136,536
+20% +$408K ﹤0.01% 2414
2019
Q1
$2.61M Sell
695,489
-357,252
-34% -$1.34M ﹤0.01% 2227
2018
Q4
$3.78M Sell
1,052,741
-100,387
-9% -$437K 0.01% 1776
2018
Q3
$6.61M Buy
1,153,128
+818,711
+245% +$4.68M 0.01% 1606
2018
Q2
$1.68M Sell
334,417
-428,879
-56% -$2.21M ﹤0.01% 2514
2018
Q1
$3.92M Buy
763,296
+19,628
+3% +$118K 0.01% 1952
2017
Q4
$4.47M Buy
743,668
+33,893
+5% +$204K 0.01% 1794
2017
Q3
$3.94M Buy
709,775
+586,690
+477% +$3.03M 0.01% 1798
2017
Q2
$571K Sell
123,085
-130,299
-51% -$582K ﹤0.01% 2748
2017
Q1
$1.25M Sell
253,384
-26,007
-9% -$250K ﹤0.01% 2264
2016
Q4
$3.1M Buy
279,391
+204,054
+271% +$1.92M 0.01% 1637
2016
Q3
$698K Sell
75,337
-122,171
-62% -$1.02M ﹤0.01% 2450
2016
Q2
$1.25M Buy
197,508
+82,934
+72% +$550K ﹤0.01% 2030
2016
Q1
$747K Buy
114,574
+2,147
+2% +$13.8K ﹤0.01% 2329
2015
Q4
$912K Sell
112,427
-45,970
-29% -$344K ﹤0.01% 2350
2015
Q3
$1.16M Buy
158,397
+131,518
+489% +$1.34M ﹤0.01% 2209
2015
Q2
$276K Sell
26,879
-30,021
-53% -$332K ﹤0.01% 2916
2015
Q1
$526K Buy
+56,900
New +$509K ﹤0.01% 2722
2014
Q4
– Sell
-34,533
Closed -$188K – 4422
2014
Q3
$188K Buy
+34,533
New +$198K ﹤0.01% 3453

Other funds holding FOMX

Millennium Management's FOMX Position: Q4 2019 in Review

Millennium Management sold out of Foamix Pharmaceuticals (FOMX) in Q4 2019, closing a stake of 345,100 shares — an estimated $1.05M sold.

Millennium Management first reported a position in FOMX in Q3 2014 and held it in 20 quarters. The position peaked at $6.61M in Q3 2018. 65 funds tracked by Wall St. Rank hold FOMX as of Q4 2019.

  • Millennium Management reported no remaining Foamix Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Millennium Management sold 345,100 Foamix Pharmaceuticals shares in Q4 2019, an estimated $1.05M.
  • Millennium Management first reported a position in Foamix Pharmaceuticals in Q3 2014 and held it in 20 quarters.
  • Millennium Management's Foamix Pharmaceuticals position peaked at $6.61M in Q3 2018.
  • 65 funds tracked by Wall St. Rank held Foamix Pharmaceuticals as of Q4 2019.

Based on Millennium Management's 13F filing for Q4 2019, filed 14 Feb 2020.